UC Davis Medicine Spring 2008 Feature No
one knew what Lyme disease was when Stephen Barthold's daughter was
diagnosed with it in 1978. At the time, Barthold and his family were
living in Connecticut, the state where the cause of the tickborne
disease would be identified four years later.
While a
course of antibiotics for an unrelated infection cured his daughter,
the father remained intrigued. Today, with 30 years of research and
more than 100 papers on Lyme disease under his belt, Barthold, a
veterinary pathologist with a joint appointment in the schools of
Medicine and Veterinary Medicine, is recognized as one of the leading
authorities on how the Lyme bacterium interacts with the hosts it
infects. When he arrived at UC Davis in 1997, Barthold lost
no time in creating an ideal home for the kind of interdisciplinary
work his research program requires: UC Davis Center for Comparative
Medicine. Housed on the west side of the Davis campus,
the unique teaching and research complex draws faculty from the schools
of Medicine and Veterinary Medicine to focus on infectious disease and
cancer research. |
 Photo: UC Davis Medical School
Center for Comparative Medicine Director Stephen Barthold is a leading expert in Lyme disease. |
"We
take advantage of the concept of ‘one medicine.' That is, since nearly
every human disease has an animal counterpart, what we learn from one
benefits the other," explains Barthold, who was recruited from Yale
School of Medicine to become the center's founding director. With
23,305 human cases reported to the CDC in 2005, Lyme disease is now the
most common vector-borne disease in the United States. Infection is
very common among domestic animals, as well. When treated with
antibiotics early, it can usually be eradicated. But,
says Barthold, "our work has shown that in the absence of antibiotic
treatment, 100 percent of animals infected with Lyme bacteria remain
infected even though they have a perfectly functional immune response."
Working with mice, Barthold has found that the bacteria, Borrelia burgdorferi,
"literally integrate themselves into collagen tissue. They colonize
little spots here and there: one joint, but not another; nervous
tissue; the heart. It varies from individual to ...
individual, which explains the disease's highly variable clinical manifestations."
In
a study to be published later this year, Barthold outlines his
discovery that even after long-term antibiotic treatment, bacteria
hidden in collagen tissue are still viable and infectious. "We're
trying to be careful in what we claim," he says, "but these findings
will be controversial."
http://aac.asm.org/cgi/content/abstract/AAC.01050-07v1 Persistence of Borrelia burgdorferi Following Antibiotic Treatment in Mice
Emir Hodzic, Sunlian Feng, Kevin Holden, Kimberly J. Freet, and Stephen W. Barthold*
Center
for Comparative Medicine, Schools of Medicine and Veterinary Medicine,
University of California at Davis, One Shields Avenue, Davis, CA 95616
Abstract
The effectiveness of antibiotic treatment was examined in a mouse model of Lyme borreliosis.
Mice
were treated with ceftriaxone or saline for one month, commencing
during the early (3 weeks) or chronic (4 months) stages of infection
with Borrelia burgdorferi. Tissues from mice were tested for infection
by culture, polymerase chain reaction (PCR), xenodiagnosis, and
transplantation of allografts at 1 and 3 months after completion of
treatment. In addition, tissues were examined for spirochetes by
immunohistochemistry.
In contrast to saline-treated mice, mice
treated with antibiotic were consistently culture-negative, but tissues
from some of the mice remained PCR-positive, and spirochetes could be
visualized in collagen-rich tissues. Furthermore, when some of the
antibiotic treated mice were fed upon by Ixodes scapularis ticks
(xenodiagnosis), spirochetes were acquired by the ticks, based upon
PCR, and ticks from those cohorts transmitted spirochetes to naïve SCID
mice, which became PCR-positive, but culture-negative.
Results indicated that following antibiotic treatment, mice remained infected with non-dividing but infectious spirochetes, particularly when antibiotic treatment was commenced during the chronic stage of infection.
Article May Be Viewed in Full at LYME BLOG www.LymeBlog.com If you want to be kept up to the minute on Lyme News, Lyme Blog is the best resource I've found... http://lymeblog.com/modules.php?name=News&file=article&sid=1345 |
|
Comments